drugset / Trial / NCT01122862

Effect of a Commercial Cosmetic Mouth Rinse on Plaque Re-growth

NCT01122862

Phase 2 Completed 23 enrolled GlaxoSmithKline
RandomizedCrossoverSingle-blindPrevention

Summary

A clinical study to evaluate the effect of a commercial mouth rinse on plaque re-growth

Timeline

Start
2010-04
Primary completion
2010-05
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Chlorhexidine Small molecule 0.12 %

Indications

No indication recorded.